Last 34.20 INR
Change Today +0.30 / 0.88%
Volume 31.8K
As of 6:06 AM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

plethico pharmaceuticals ltd (PLEP) Snapshot

Open
34.25
Previous Close
33.90
Day High
35.85
Day Low
34.00
52 Week High
06/12/14 - 74.30
52 Week Low
02/27/15 - 32.70
Market Cap
1.2B
Average Volume 10 Days
48.9K
EPS TTM
36.01
Shares Outstanding
34.1M
EX-Date
09/22/11
P/E TM
0.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for PLETHICO PHARMACEUTICALS LTD (PLEP)

Related News

No related news articles were found.

plethico pharmaceuticals ltd (PLEP) Related Businessweek News

No Related Businessweek News Found

plethico pharmaceuticals ltd (PLEP) Details

Plethico Pharmaceuticals Limited engages in the manufacture, marketing, and distribution of pharmaceutical and allied healthcare products in the nutraceuticals and herbal segments in India and internationally. It provides nutraceutical products, such as dietary supplements under the Natrol brand; and sports nutrition products, including HSP protein supplement for enhanced training, Pro NOS whey protein, and Black Powder pre workout energy boosting formula, as well as Prolab and Coach’s Formula sports nutrition product. The company’s nutraceutical products also comprise flavored herbal teas under the Laci Le Beau brand; NuHair and Shen Min hair products containing a serum and vitamins targeted at combating hair loss; and Promensil for relief of menopause symptoms, as well as Trinovin for maintaining prostate and urinary health. In addition, it offers herbal healthcare products, including a range of herbal products for cough and sore throat in the drops, syrups, and lozenges forms under the Travisil brand; Mountain Herbz range of herbal medicines and supplements to treat high blood pressure, digestions, and aphrodisiacs; medicated lozenges sold under the Actifresh brand; Travopassit, an anti-stress product; and Byte and Myntz products. Further, the company provides anti-malarial, anti-tubercular, anti-infective, pain, cardiac, gastro, and cough and cold products. Plethico Pharmaceuticals Limited was founded in 1963 and is based in Mumbai, India.

Founded in 1963

plethico pharmaceuticals ltd (PLEP) Top Compensated Officers

Executive Chairman and Managing Director
Total Annual Compensation: 2.2M
Chief-Executive Officer, Whole-Time Director,...
Total Annual Compensation: 2.2M
Compensation as of Fiscal Year 2014.

plethico pharmaceuticals ltd (PLEP) Key Developments

Plethico Pharmaceuticals Limited Reports Unaudited Standalone and Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Plethico Pharmaceuticals Limited reported unaudited standalone and consolidated earnings results for the third quarter and nine months ended December 31, 2014. For the quarter on standalone basis, the company reported net sales income from operations of INR 173.956 million against INR 759.080 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 9.117 million against profit from operations before other income, finance costs and exceptional items of INR 12.772 million a year ago. Loss from ordinary activities before tax was INR 123.592 million against INR 97.342 million a year ago. Net loss for the period was INR 123.592 million against INR 67.949 million a year ago. Loss per share before and after extraordinary items basic and diluted was INR 3.63 against INR 1.99 per share a year ago. For nine months on standalone basis, the company reported net sales income from operations of INR 1,154.451 million against INR 3,181.126 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 24.613 million against INR 338.571 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 24.613 million against INR 338.571 million a year ago. Loss from ordinary activities before tax was INR 303.828 million against INR 19.888 million a year ago. Net loss for the period was INR 303.828 million against INR 24.153 million a year ago. Loss per share before and after extraordinary items basic and diluted was INR 8.92 against INR 0.71 per share a year ago. For the quarter on consolidated basis, the company reported net sales income from operations of INR 1,081.956 million against INR 3,640.407 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 75.117 million against INR 723.053 million a year ago. Loss from ordinary activities before tax was INR 40.658 million against INR 433.173 million a year ago. Net loss for the period was INR 40.658 million against INR 440.673 million a year ago. Loss per share before and after extraordinary items basic and diluted was INR 1.19 against INR 1.85 per share a year ago. For the nine months on consolidated basis, the company reported net sales income from operations of INR 6,443.532 million against INR 12,678.209 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 791.545 million against INR 1,883.944 million a year ago. Loss from ordinary activities before tax was INR 206.445 million against INR 1,054.108 million a year ago. Net loss for the period was INR 120.495 million against net profit for the period of INR 1,094.413 million a year ago. Loss per share before and after extraordinary items basic and diluted was INR 3.54 against earnings per share before and after extraordinary items basic and diluted of INR 32.13 per share a year ago.

Plethico Pharmaceuticals Limited Announces Resignation of Dr. G. N. Qazi as Independent Non-Executive Director

Plethico Pharmaceuticals Limited announced that the Board of Directors at their meeting held on February 14, 2015, accepted the resignation of Dr. G. N. Qazi as Independent Non-Executive Director of the company.

Plethico Pharmaceuticals Limited Announces Change of Corporate Address

Plethico Pharmaceuticals Limited in its board meeting held on February 14, 2015, announced the shifting of corporate office of the company from Sabnam House, Plot No.A-15/16, Central Cross Road-B, M.I.D.C Andheri (E), Mumbai-400093 to Shop No: 262, Lower. Ground Floor, Dreams the Mall, L B S Marg, Bhandup (W), Mumbai - 400078.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PLEP:IN 34.20 INR +0.30

PLEP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $47.42 USD +0.05
Amway Malaysia Hldgs Bhd 11.14 MYR 0.00
Endo International PLC $87.58 USD +1.98
Kellogg Co $64.58 USD +0.10
Wyeth Ltd 1,334 INR 0.00
View Industry Companies
 

Industry Analysis

PLEP

Industry Average

Valuation PLEP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.1x
Price/Book 0.1x
Price/Cash Flow 3.5x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PLETHICO PHARMACEUTICALS LTD, please visit www.plethico.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.